SCHEMBL22859643

SCHEMBL22859643

CCOC(=O)c1cn(CCNS)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.45
CYP1A2 P05177 2/20 0.41
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 1/20 0.40
GAA P10253 2/20 0.38
SMYD3 Q9H7B4 1/20 0.38
POLB P06746 1/20 0.37
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 2/20 0.36
CPB2 Q96IY4 1/20 0.36
TBXAS1 P24557 1/20 0.36
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20868509 0.89 NOTUM (0.45) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL28934829 0.85 NOTUM (0.49) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL23059425 0.85 NOTUM (0.43) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL22480272 0.85 NOTUM (0.43) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL25884465 0.84 NOTUM (0.42) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL24036185 0.84 NOTUM (0.48) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL20857112 0.82 NOTUM (0.47) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL29065096 0.82 NOTUM (0.47) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL20857079 0.82 NOTUM (0.40) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL20857078 0.82 NOTUM (0.40) NOTUMCYP1A2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210002433-A1 BIOCOMPATIBLE HYDROGEL CAPSULES AND PROCESS FOR PREPARING SAME SIGILON THERAPEUTICS, INC. 2021-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002433-A1 BIOCOMPATIBLE HYDROGEL CAPSULES AND PROCESS FOR PREPARING SAME ACMSD, ALG1, COL2A1 NOTUM 1318/4885CYP1A2 4214/4885KDM4E 3426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.